Reyes-Botero, Germán <br/><br/>
Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG).  [electronic resource] 

 -  The oncologist  05 2018 
 - 524-e44 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2017-0689  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bevacizumab--pharmacology<br/>Female<br/>Glioblastoma--drug therapy<br/>Humans<br/>Male<br/>Temozolomide--pharmacology